Midwest Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$841K Sell
4,423
-471
-10% -$81K 0.01% 374
2026
Q1
$826K Buy
4,894
+1,343
+38% +$230K 0.01% 363
2025
Q4
$599K Buy
3,551
+229
+7% +$37.2K 0.01% 405
2025
Q3
$480K Sell
3,322
-248
-7% -$33.9K 0.01% 425
2025
Q2
$452K Buy
+3,570
New +$438K 0.01% 437

Other funds holding IBB

Midwest Trust's IBB Position: Q2 2026 in Review

Midwest Trust reduced its iShares Biotechnology ETF (IBB) stake by 9.6% in Q2 2026, selling an estimated $81K and leaving 4,423 shares worth $841K. The position accounts for 0.01% of the portfolio, ranked #374.

Midwest Trust first reported a position in IBB in Q2 2025 and has held it in 5 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Midwest Trust held 4,423 shares of iShares Biotechnology ETF worth $841K as of Q2 2026.
  • Midwest Trust sold 471 iShares Biotechnology ETF shares in Q2 2026, an estimated $81K.
  • iShares Biotechnology ETF made up 0.01% of Midwest Trust's portfolio in Q2 2026, its #374 holding.
  • Midwest Trust first reported a position in iShares Biotechnology ETF in Q2 2025 and has held it in 5 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.